NCT00577447View on ClinicalTrials.gov

Docosahexaenoic Acid in the Treatment of Autism

NACompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

October 31, 2005

Primary Completion Date

September 30, 2007

Study Completion Date

November 30, 2007

Conditions
Autism
Interventions
DIETARY_SUPPLEMENT

docosahexaenoic acid (DHA)

Capsule containing 200mg of DHA

DIETARY_SUPPLEMENT

Placebo

Placebo capsule containing corn and soybean oil

Trial Locations (1)

55905

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
collaborator

DSM Nutritional Products, Inc.

INDUSTRY

lead

Mayo Clinic

OTHER